View Future GrowthCHAPTERS Group 과거 순이익 실적과거 기준 점검 0/6CHAPTERS Group 의 수입은 연평균 -52.5%의 비율로 감소해 온 반면, Diversified Financial 산업은 연평균 9.4%의 비율로 감소했습니다. 매출은 연평균 47%의 비율로 증가해 왔습니다.핵심 정보-52.54%순이익 성장률-30.76%주당순이익(EPS) 성장률Diversified Financial 산업 성장률9.07%매출 성장률46.95%자기자본이익률-12.82%순이익률-16.40%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • May 28Full year 2025 earnings: Revenues exceed analyst expectationsFull year 2025 results: Revenue: €210.5m (up 90% from FY 2024). Net loss: €29.6m (loss widened 159% from FY 2024). Revenue exceeded analyst estimates by 15%. Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Diversified Financial industry in Germany.Reported Earnings • Oct 22First half 2024 earnings released: €0.23 loss per share (vs €0.18 loss in 1H 2023)First half 2024 results: €0.23 loss per share (further deteriorated from €0.18 loss in 1H 2023). Revenue: €50.0m (up 49% from 1H 2023). Net loss: €4.48m (loss widened 49% from 1H 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Diversified Financial industry in Germany. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.Reported Earnings • May 28Full year 2023 earnings releasedFull year 2023 results: Revenue: €78.3m (up 86% from FY 2022). Net loss: €4.08m (loss narrowed 38% from FY 2022). Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.Reported Earnings • Oct 05First half 2023 earnings released: €0.25 loss per share (vs €0.035 profit in 1H 2022)First half 2023 results: €0.25 loss per share (down from €0.035 profit in 1H 2022). Revenue: €33.7m (up 77% from 1H 2022). Net loss: €4.20m (down €4.72m from profit in 1H 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 49% per year whereas the company’s share price has increased by 45% per year.Reported Earnings • May 30Full year 2021 earnings released: €0.21 loss per share (vs €0.68 loss in FY 2020)Full year 2021 results: €0.21 loss per share (up from €0.68 loss in FY 2020). Revenue: €28.7m (up €27.6m from FY 2020). Net loss: €2.27m (flat on FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.Reported Earnings • Sep 22First half 2021 earnings releasedFirst half 2021 results: Net income: €15.7k (up €29.8k from 1H 2020).모든 업데이트 보기Recent updates공고 • Jul 24CHAPTERS Group AG announced that it has received €63.921396 million in fundingCHAPTERS Group AG announced a private placement of 1,521,938 Common Shares of the company at an issue price of € 42 and raised gross proceeds of € 63,921,396 on July 22, 2026. Subject to the registration of the implementation of the capital increase in the Commercial Register, the Company's share capital will increase from € 23,842,152.00 to € 25,364,090.00. The transaction was supported by four of the company’s largest long-term shareholders, including Mitch Rales, Stravaigin, the family office of Daniel Ek and Sator Grove Holdings, and one additional institutional shareholder, further reinforcing their shared commitment to CHAPTERS’ long-term growth strategy.Price Target Changed • Jul 20Price target increased by 7.8% to €48.50Up from €45.00, the current price target is an average from 2 analysts. New target price is 27% above last closing price of €38.15. Stock is down 11% over the past year. The company is forecast to post a net loss per share of €0.59 next year compared to a net loss per share of €1.24 last year.공고 • Jun 02CHAPTERS Group AG, Annual General Meeting, Jul 16, 2026CHAPTERS Group AG, Annual General Meeting, Jul 16, 2026, at 14:00 W. Europe Standard Time.Reported Earnings • May 28Full year 2025 earnings: Revenues exceed analyst expectationsFull year 2025 results: Revenue: €210.5m (up 90% from FY 2024). Net loss: €29.6m (loss widened 159% from FY 2024). Revenue exceeded analyst estimates by 15%. Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Diversified Financial industry in Germany.Price Target Changed • May 20Price target decreased by 8.2% to €45.00Down from €49.00, the current price target is an average from 2 analysts. New target price is 47% above last closing price of €30.60. Stock is down 19% over the past year. The company is forecast to post a net loss per share of €0.69 next year compared to a net loss per share of €0.50 last year.공고 • Jun 02CHAPTERS Group AG, Annual General Meeting, Jul 09, 2025CHAPTERS Group AG, Annual General Meeting, Jul 09, 2025, at 14:00 W. Europe Standard Time.공고 • May 23Expatrio Global Services GmbH agreed to acquire Fintiba GmbH from CHAPTERS Group AG (XTRA:CHG).Expatrio Global Services GmbH agreed to acquire Fintiba GmbH from CHAPTERS Group AG (XTRA:CHG) on May 22, 2025. Bastian Krieghoff, CEO of Fintiba, will be appointed to the Executive Board of CHAPTERS Group AG by the Supervisory Board. The transaction is subject to the usual contractual conditions is expected to close in May 2025.Reported Earnings • Oct 22First half 2024 earnings released: €0.23 loss per share (vs €0.18 loss in 1H 2023)First half 2024 results: €0.23 loss per share (further deteriorated from €0.18 loss in 1H 2023). Revenue: €50.0m (up 49% from 1H 2023). Net loss: €4.48m (loss widened 49% from 1H 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Diversified Financial industry in Germany. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.공고 • Oct 18CHAPTERS Group AG (XTRA:CHG) acquired Xplain AG.CHAPTERS Group AG (XTRA:CHG) acquired Xplain AG on October 18, 2024. Xplain includes the two companies Xplain AG and the Spanish development partner Xplain Ibérica. Both will continue to operate independently, as Andreas Löwinger, CEO of Xplain AG, told the Keystone-SDA news agency. The total of 60 employees of both companies will keep their jobs. All projects will also be continued. Löwinger will remain CEO until a successor is found. CHAPTERS Group AG (XTRA:CHG) completed the acquisition of Xplain AG on October 18, 2024.New Risk • Jun 06New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 10.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Shareholders have been diluted in the past year (10.0% increase in shares outstanding).공고 • Jun 05CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024, at 14:00 W. Europe Standard Time.Reported Earnings • May 28Full year 2023 earnings releasedFull year 2023 results: Revenue: €78.3m (up 86% from FY 2022). Net loss: €4.08m (loss narrowed 38% from FY 2022). Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Shareholders have been diluted in the past year (10.0% increase in shares outstanding).New Risk • Nov 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 8.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.3% average weekly change). Minor Risk Shareholders have been diluted in the past year (10.0% increase in shares outstanding).Reported Earnings • Oct 05First half 2023 earnings released: €0.25 loss per share (vs €0.035 profit in 1H 2022)First half 2023 results: €0.25 loss per share (down from €0.035 profit in 1H 2022). Revenue: €33.7m (up 77% from 1H 2022). Net loss: €4.20m (down €4.72m from profit in 1H 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 49% per year whereas the company’s share price has increased by 45% per year.New Risk • Oct 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (10% increase in shares outstanding).New Risk • Sep 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company.Reported Earnings • May 30Full year 2021 earnings released: €0.21 loss per share (vs €0.68 loss in FY 2020)Full year 2021 results: €0.21 loss per share (up from €0.68 loss in FY 2020). Revenue: €28.7m (up €27.6m from FY 2020). Net loss: €2.27m (flat on FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.Reported Earnings • Sep 22First half 2021 earnings releasedFirst half 2021 results: Net income: €15.7k (up €29.8k from 1H 2020).Reported Earnings • Jun 29Full year 2020 earnings releasedFull year 2020 results: Net loss: €2.27m (loss narrowed 55% from FY 2019).Is New 90 Day High Low • Feb 12New 90-day high: €5.55The company is up 17% from its price of €4.76 on 13 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 5.0% over the same period.Is New 90 Day High Low • Jan 27New 90-day low: €4.24The company is down 9.0% from its price of €4.68 on 28 October 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 11% over the same period.Is New 90 Day High Low • Dec 18New 90-day low: €4.40The company is down 9.0% from its price of €4.84 on 18 September 2020. The German market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is flat over the same period.Is New 90 Day High Low • Oct 01New 90-day low: €4.76The company is down 16% from its price of €5.70 on 03 July 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 9.0% over the same period.매출 및 비용 세부 내역CHAPTERS Group가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이DB:CHG 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Dec 25181-305030 Sep 25156-265030 Jun 25132-235031 Mar 25121-175031 Dec 24111-115030 Sep 2499-94030 Jun 2487-63031 Mar 2479-53031 Dec 2371-43030 Sep 2364-72030 Jun 2357-92031 Mar 2349-82031 Dec 2242-62030 Sep 2245-42030 Jun 2248-22031 Mar 2238-22031 Dec 2129-21030 Sep 2114-21030 Jun 210-20031 Mar 211-20031 Dec 201-21030 Sep 201-40030 Jun 201-50031 Mar 201-50031 Dec 190-50030 Sep 19110030 Jun 19180031 Mar 19280031 Dec 18381030 Sep 18340030 Jun 18300031 Mar 18300031 Dec 17310030 Sep 17300030 Jun 17300031 Mar 17300031 Dec 16300030 Sep 16300030 Jun 16300031 Mar 16300031 Dec 15300030 Sep 153000양질의 수익: CHG 은(는) 현재 수익성이 없습니다.이익 마진 증가: CHG는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: CHG은 수익성이 없으며 지난 5년 동안 손실이 연평균 52.5% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 CHG의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: CHG은 수익성이 없어 지난 해 수익 성장률을 Diversified Financial 업계(9.2%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: CHG는 현재 수익성이 없으므로 자본 수익률이 음수(-12.82%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YDiversified-financials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/11 11:46종가2026/08/11 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스CHAPTERS Group AG는 2명의 분석가가 다루고 있습니다. 이 중 2명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Andreas WolfBerenbergAlexander Zienkowiczmwb research AG
Reported Earnings • May 28Full year 2025 earnings: Revenues exceed analyst expectationsFull year 2025 results: Revenue: €210.5m (up 90% from FY 2024). Net loss: €29.6m (loss widened 159% from FY 2024). Revenue exceeded analyst estimates by 15%. Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Diversified Financial industry in Germany.
Reported Earnings • Oct 22First half 2024 earnings released: €0.23 loss per share (vs €0.18 loss in 1H 2023)First half 2024 results: €0.23 loss per share (further deteriorated from €0.18 loss in 1H 2023). Revenue: €50.0m (up 49% from 1H 2023). Net loss: €4.48m (loss widened 49% from 1H 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Diversified Financial industry in Germany. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.
Reported Earnings • May 28Full year 2023 earnings releasedFull year 2023 results: Revenue: €78.3m (up 86% from FY 2022). Net loss: €4.08m (loss narrowed 38% from FY 2022). Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.
Reported Earnings • Oct 05First half 2023 earnings released: €0.25 loss per share (vs €0.035 profit in 1H 2022)First half 2023 results: €0.25 loss per share (down from €0.035 profit in 1H 2022). Revenue: €33.7m (up 77% from 1H 2022). Net loss: €4.20m (down €4.72m from profit in 1H 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 49% per year whereas the company’s share price has increased by 45% per year.
Reported Earnings • May 30Full year 2021 earnings released: €0.21 loss per share (vs €0.68 loss in FY 2020)Full year 2021 results: €0.21 loss per share (up from €0.68 loss in FY 2020). Revenue: €28.7m (up €27.6m from FY 2020). Net loss: €2.27m (flat on FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.
Reported Earnings • Sep 22First half 2021 earnings releasedFirst half 2021 results: Net income: €15.7k (up €29.8k from 1H 2020).
공고 • Jul 24CHAPTERS Group AG announced that it has received €63.921396 million in fundingCHAPTERS Group AG announced a private placement of 1,521,938 Common Shares of the company at an issue price of € 42 and raised gross proceeds of € 63,921,396 on July 22, 2026. Subject to the registration of the implementation of the capital increase in the Commercial Register, the Company's share capital will increase from € 23,842,152.00 to € 25,364,090.00. The transaction was supported by four of the company’s largest long-term shareholders, including Mitch Rales, Stravaigin, the family office of Daniel Ek and Sator Grove Holdings, and one additional institutional shareholder, further reinforcing their shared commitment to CHAPTERS’ long-term growth strategy.
Price Target Changed • Jul 20Price target increased by 7.8% to €48.50Up from €45.00, the current price target is an average from 2 analysts. New target price is 27% above last closing price of €38.15. Stock is down 11% over the past year. The company is forecast to post a net loss per share of €0.59 next year compared to a net loss per share of €1.24 last year.
공고 • Jun 02CHAPTERS Group AG, Annual General Meeting, Jul 16, 2026CHAPTERS Group AG, Annual General Meeting, Jul 16, 2026, at 14:00 W. Europe Standard Time.
Reported Earnings • May 28Full year 2025 earnings: Revenues exceed analyst expectationsFull year 2025 results: Revenue: €210.5m (up 90% from FY 2024). Net loss: €29.6m (loss widened 159% from FY 2024). Revenue exceeded analyst estimates by 15%. Revenue is forecast to grow 28% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Diversified Financial industry in Germany.
Price Target Changed • May 20Price target decreased by 8.2% to €45.00Down from €49.00, the current price target is an average from 2 analysts. New target price is 47% above last closing price of €30.60. Stock is down 19% over the past year. The company is forecast to post a net loss per share of €0.69 next year compared to a net loss per share of €0.50 last year.
공고 • Jun 02CHAPTERS Group AG, Annual General Meeting, Jul 09, 2025CHAPTERS Group AG, Annual General Meeting, Jul 09, 2025, at 14:00 W. Europe Standard Time.
공고 • May 23Expatrio Global Services GmbH agreed to acquire Fintiba GmbH from CHAPTERS Group AG (XTRA:CHG).Expatrio Global Services GmbH agreed to acquire Fintiba GmbH from CHAPTERS Group AG (XTRA:CHG) on May 22, 2025. Bastian Krieghoff, CEO of Fintiba, will be appointed to the Executive Board of CHAPTERS Group AG by the Supervisory Board. The transaction is subject to the usual contractual conditions is expected to close in May 2025.
Reported Earnings • Oct 22First half 2024 earnings released: €0.23 loss per share (vs €0.18 loss in 1H 2023)First half 2024 results: €0.23 loss per share (further deteriorated from €0.18 loss in 1H 2023). Revenue: €50.0m (up 49% from 1H 2023). Net loss: €4.48m (loss widened 49% from 1H 2023). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 14% growth forecast for the Diversified Financial industry in Germany. Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has increased by 40% per year, which means it is well ahead of earnings.
공고 • Oct 18CHAPTERS Group AG (XTRA:CHG) acquired Xplain AG.CHAPTERS Group AG (XTRA:CHG) acquired Xplain AG on October 18, 2024. Xplain includes the two companies Xplain AG and the Spanish development partner Xplain Ibérica. Both will continue to operate independently, as Andreas Löwinger, CEO of Xplain AG, told the Keystone-SDA news agency. The total of 60 employees of both companies will keep their jobs. All projects will also be continued. Löwinger will remain CEO until a successor is found. CHAPTERS Group AG (XTRA:CHG) completed the acquisition of Xplain AG on October 18, 2024.
New Risk • Jun 06New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 10.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Shareholders have been diluted in the past year (10.0% increase in shares outstanding).
공고 • Jun 05CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024CHAPTERS Group AG, Annual General Meeting, Jul 09, 2024, at 14:00 W. Europe Standard Time.
Reported Earnings • May 28Full year 2023 earnings releasedFull year 2023 results: Revenue: €78.3m (up 86% from FY 2022). Net loss: €4.08m (loss narrowed 38% from FY 2022). Revenue is forecast to grow 19% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Healthcare Services industry in Europe.
New Risk • Apr 16New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Shareholders have been diluted in the past year (10.0% increase in shares outstanding).
New Risk • Nov 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 8.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (8.3% average weekly change). Minor Risk Shareholders have been diluted in the past year (10.0% increase in shares outstanding).
Reported Earnings • Oct 05First half 2023 earnings released: €0.25 loss per share (vs €0.035 profit in 1H 2022)First half 2023 results: €0.25 loss per share (down from €0.035 profit in 1H 2022). Revenue: €33.7m (up 77% from 1H 2022). Net loss: €4.20m (down €4.72m from profit in 1H 2022). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 7.6% growth forecast for the Healthcare Services industry in Europe. Over the last 3 years on average, earnings per share has increased by 49% per year whereas the company’s share price has increased by 45% per year.
New Risk • Oct 02New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of German stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Shareholders have been diluted in the past year (10% increase in shares outstanding).
New Risk • Sep 05New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 50% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. This is currently the only risk that has been identified for the company.
Reported Earnings • May 30Full year 2021 earnings released: €0.21 loss per share (vs €0.68 loss in FY 2020)Full year 2021 results: €0.21 loss per share (up from €0.68 loss in FY 2020). Revenue: €28.7m (up €27.6m from FY 2020). Net loss: €2.27m (flat on FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 111 percentage points per year, which is a significant difference in performance.
Reported Earnings • Sep 22First half 2021 earnings releasedFirst half 2021 results: Net income: €15.7k (up €29.8k from 1H 2020).
Reported Earnings • Jun 29Full year 2020 earnings releasedFull year 2020 results: Net loss: €2.27m (loss narrowed 55% from FY 2019).
Is New 90 Day High Low • Feb 12New 90-day high: €5.55The company is up 17% from its price of €4.76 on 13 November 2020. The German market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Healthcare Services industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Jan 27New 90-day low: €4.24The company is down 9.0% from its price of €4.68 on 28 October 2020. The German market is up 16% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 11% over the same period.
Is New 90 Day High Low • Dec 18New 90-day low: €4.40The company is down 9.0% from its price of €4.84 on 18 September 2020. The German market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is flat over the same period.
Is New 90 Day High Low • Oct 01New 90-day low: €4.76The company is down 16% from its price of €5.70 on 03 July 2020. The German market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Healthcare Services industry, which is up 9.0% over the same period.